1/10
Vocabulary flashcards covering clinical pharmacology, indications, contraindications, special clinical notes, and adult/paediatric dosing protocols for morphine as issued by the Queensland Ambulance Service (QAS).
Drug Class
Narcotic analgesic
Pharmacology
Acts on the central nervous system by binding with opioid receptors, altering pain perception and emotional response to pain; combines to cause respiratory depression, vasodilation, decreases in the gag reflex, and slows AV node conduction.
Metabolism
Metabolised by the liver, kidney, and lungs.
Indications
Significant pain
Sedation
Autonomic dysreflexia (with systolic BP >160mmHg).
Contraindications
Known allergy AND/OR Adverse Drug Reaction
Kidney disease (renal failure).
Precautions
Hypotension
Respiratory tract burns
Respiratory depression and/or failure
Known addiction to narcotics
Concurrent MAOI therapy
Cardiac chest pain.
Side Effects
Bradycardia
Drowsiness
Hypotension
Nausea and/or vomiting
Pin point pupils
Respiratory depression.
Presentation
Ampoule containing 10mg/1mL morphine sulphate pentahydrate.
Pharmacokinetics
Onset: 5–10minutes (peak 20–30minutes IM) or 2–5minutes (peak 20minutes IV)
Duration: 1–2hours
Half-life: 2hours.
Adult Dosages
Significant pain: 2.5mg-5mg IV or 2.5mg-10mg IM, both repeated at up to 5mg every 5 minutes, no max dose.
Sedation: 2.5mg IV & IO, repeated every 5 minutes, no max dose.
Paediatric dosages
IM:
200microg/kg, single max dose 5mg repeated at 100microg/kg (max 2.5mg), 10 minute intervals, no max dose. (Significant pain and autonomic dysreflexia)
IV:
100microg/kg, single max dose 2.5mg, repeated every 5 minutes at 50microg/kg (max 2.5mg), no max dose (significant pain and autonomic dysreflexia)
IV & IO:
100microg/kg, single max dose 2.5mg, repeated PRN, no max dose (sedation)